T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
7 clinical trials · Condition
◉ Watch T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275) | National Cancer Institute (NCI) | 2021-05-20 |
| Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma (NCT04231877) | University of Washington | 2020-10-27 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714) | Northwestern University | 2018-11-20 |
Track T-Cell/Histiocyte-Rich Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.